<p>A novel gene therapy for hearing loss was administered to six children in China in a clinical trial co-led by investigators at Mass Eye and Ear in Boston and Eye & ENT Hospital of Fudan University in Shanghai, China. Each child had an inherited deafness caused by mutations in the <em>OTOF </em>gene<em>,</em> called DFNB9. The researchers report in a new study in <em>The Lancet</em>, after 26 weeks, five children demonstrated hearing recovery and dramatic improvements in speech perception and the restored ability to conduct normal conversation. With its first patient treated in December 2022, this research represents the first human clinical trial to administer gene therapy for treating this form of hearing loss, with the most patients treated and longest follow-up conducted to date.</p>
Creating a startup without a fixed idea is like building a startup backward. But that’s precisely how our startup, Zupyak, unfolded and it worked. Our…
Non-Canonical Functions of EZH2 in Prostate Cancer Revealed miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
The Chinese automotive market places special demands on vehicle technology. Therefore Porsche Engineering is continuously expanding its local presence: Roughly 130 employees develop, test and validate China-specific functions for the intelligent and connected vehicle. The details.